|
John L. Higgins was elected a Director in May 2004. Mr. Higgins is President and Chief Executive Officer of Ligand Pharmaceuticals Inc. a publicly traded biotech company since January 2007 and has served as a director since February 2007. He was most recently Chief Financial Officer at Connetics since 1997 and also served as Executive Vice President Finance and Administration and Corporate Development since January 2002 until its acquisition by Stiefel Laboratories Inc. in December 2006. Before joining Connetics he was a member of the executive management team at BioCryst. Before joining BioCryst in 1994 Mr. Higgins was a member of the healthcare banking team of Dillon Read & Co. Inc. an investment banking firm. He received his A.B. from Colgate University. | 